<DOC>
	<DOCNO>NCT00455117</DOCNO>
	<brief_summary>Aim trial : To investigate whether post-craniotomy analgesia ( ) intravenous ( IV ) parecoxib plus intravenous paracetamol superior ( ii ) intravenous paracetamol alone . Study Hypothesis : Post-operative analgesia intravenous parecoxib combination intravenous paracetamol superior intravenous paracetamol alone .</brief_summary>
	<brief_title>Effect Parecoxib Post-craniotomy Pain</brief_title>
	<detailed_description>Neurosurgical patient undergo brain procedure ( craniotomy patient ) know suffer moderately severe postoperative pain high rate post-operative nausea vomit . Post-craniotomy pain poorly treat 50 % craniotomy patient experience postoperative pain moderate severe intensity . Fear drug complication sedation , respiratory depression , seizures intracranial bleeding inhibit prescribe effective pain treatment.Non-steroidal anti-inflammatory drug ( NSAIDS ) know effective analgesic peri-operative period however use cranial neurosurgery limit due risk bleeding . Parecoxib injectable form NSAID work inhibit cyclo-oxygenase type-2 ( COX-2 ) . The main benefit COX-2 inhibitor minimal inhibition platelet function therefore minimal risk increase bleeding.This project aim evaluate whether parecoxib effective pain reliever ( analgesic ) brain surgery . Patients age 18-65 year present elective craniotomy randomly allocate two different analgesic program ( ) IV parecoxib IV paracetamol ( ii ) IV paracetamol . All patient receive standardise anaesthetic . Scalp infiltration , use 20mls local anesthetic ( bupivacaine 0.5 % adrenaline ) , occur prior skin incision . Intermittent morphine administration use post-operatively ensure adequate analgesia arm trial . Immediate post-operative adjunctive analgesia provide nurse administer IV morphine post-anaesthetic care unit ( PACU ) per protocol ( RMH protocol opioid titration ) , follow patient control analgesia ( PCA ) morphine verbal rating scale &lt; 4 ( rating ten ) . A score less four consider mild pain . PCA continue first twenty-four hour discontinue . Patients receive strict oral paracetamol nurse administer IV morphine require . The primary study endpoint morphine consumption first 24 hour . Data analyse intention treat basis . Continuous variable graph determine distribution . Normally distributed variable describe use mean standard deviation compare use Student 's t-tests . Skewed variable describe use median range ( interquartile range ) compare use Wilcoxon rank sum test . A p-value le 0.05 consider statistically significant .</detailed_description>
	<mesh_term>Parecoxib</mesh_term>
	<criteria>Supratentorial craniotomy , glasgow coma scale 15 Chronic pain , Chronic opioid use . History significant alcohol benzodiazepine ( BZD ) use , Inability speak English , Preoperative aphasia dysphasia , Renal impairment ( Creatinine level &gt; 0.1 ) , Asthma ( evidence reversible airway obstruction , Known ischaemic heart disease cerebrovascular disease , American Society Anaesthesiologists ( ASA ) grade IV V , Allergy study drug ( paracetamol , parecoxib , sulpha , morphine , bupivacaine , propofol , remifentanil ; Administration oral paracetamol within previous 8 hour . Pregnancy breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>analgesia</keyword>
	<keyword>pain</keyword>
	<keyword>neurosurgery</keyword>
	<keyword>NSAIDS</keyword>
	<keyword>parecoxib</keyword>
	<keyword>morphine consumption</keyword>
</DOC>